Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Prof. Joerg Walter Bartsch

Professor/Lab Head

Philipps-Universität Marburg Fachbereich Medizin

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

70%

Pharmacology

50%

Cancer Biology

90%

Targeted Therapy

30%

Antioxidant Therapy

20%

Astrocyte Biology

20%

Tumorigenesis

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1

Article Link

Year:

2024

A disintegrin and metalloproteinase 22 activates integrin <b>β</b>1 through its disintegrin domain to promote the progression of pituitary adenoma

Article Link

Year:

2024

Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells

Article Link

Year:

2023

Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis

Article Link

Year:

2023

Basal cell adhesion molecule promotes metastasis‐associated processes in ovarian cancer

Article Link

Year:

2023

Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice

Article Link

Year:

2023

A jack of all trades – ADAM8 as a signaling hub in inflammation and cancer

Article Link

Year:

2023

The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma

Article Link

Year:

2022

Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide

Article Link

Year:

2022

PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT/ERK signaling.

Article Link

Year:

2022

Radiogenomic Predictors of Recurrence in Glioblastoma—A Systematic Review

Article Link

Year:

2022

ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and MMP-9

Article Link

Year:

2022

Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells

Article Link

Year:

2021

Targeting Aggressive Pituitary Adenomas at the Molecular Level—A Review

Article Link

Year:

2021

Comparison of Whiskbroom and Pushbroom darkfield elastic light scattering spectroscopic imaging for head and neck cancer identification in a mouse model

Article Link

Year:

2021

Collaborators13

Carsten Culmsee

Profesor for Clinical Pharmacy

Philipps-Universität Marburg

GERMANY

Carlos Barcia

Associate Professor

University of Barcelona

SPAIN

Robert Mandic

University Hospital Marburg

GERMANY

Regina Verena Taudte

Assistant Professor

Philipps-Universität Marburg

GERMANY

Inês Sequeira

Associate Professor and Deputy Director of Research

Queen Mary University of London

UNITED KINGDOM

Ana Paula Candiota

Professor Agregat Laboral

University of Barcelona

SPAIN

Tillmann Rusch

Philipps-Universität Marburg

GERMANY

Mona Knoblich

Reutlingen University

GERMANY

Benjamin Voellger

Head of Department

GERMANY

Christian Preußer

Heading EV Core Facility

Philipps-Universität Marburg

GERMANY

Johannes Graumann

Professor of Translational Proteomics

Philipps-Universität Marburg

GERMANY

Miriam H. A. Bopp

University of Marburg

GERMANY

Christopher Nimsky

Professor & Chairman

Philipps-Universität Marburg

GERMANY

How do I reach out?

Meet Kite AI